Diagnostic antibodies and antigens for autoimmune disease testing: MPA, CCP

Autoimmune diseases occur when the immune system attacks the normal tissue within joints, vasculature, and other organ systems, causing inflammation, pain, diminished mobility, fatigue, and other non-specific symptoms.1 The strong overlap of signs and symptoms among the autoimmune diseases can lead to delays in diagnosis and appropriate treatment. However, immunodiagnostics has been developed to detect the autoimmune disease at an early stage. biomarkers such as Mycophenolic acid (MPA) and Cyclic citrullinated peptide (CCP) and so on have been developed to detect the autoimmune disease at an early stage of organ transplantation and rheumatoid arthritis, respectively.

GENEMEDI developed the antigens and antibodies for rapid kit such as Competitive immunoassay validation (Competitive ELISA) with hapten-carrier conjugates and anti-Hapten antibody, and Lateral flow immunoassay (LFIA) to detect the autoimmune disease.

Genemedi supplies antibodies and antigens for autoimmune disease testing for a wide selection of choices (please see below).